We are building upon our strong heritage in bronchodilator and inhaler development with ongoing clinical development programmes aimed at improving the outlook for people with COPD. COPD is a ...

This study demonstrates that there is no benefit of inhaled short-acting ß-agonists prior to bronchoscopy in patients with COPD. The inhalation of salbutamol neither improved safety nor prevented ...

Conclusion: Tiotropium appears to be at least as effective as currently available alternatives in the treatment of patients with COPD who require daily bronchodilator treatment. Its simplified ...

Treatments such as asthma bronchodilators already target ... trials are planned in which patients with asthma and COPD will try out statin inhalers for safety and effectiveness.

The drug has a marketing authorisation in a pressurised metered-dose inhaler (pMDI), as a maintenance dual bronchodilator to relieve symptoms in adults with COPD. Bevespi, which is taken twice ...

COPD is a disease that damages your ... They’re typically taken through an inhaler or nebulizer. Short-acting bronchodilators last 4 to 6 hours, and you only use them when you need them.